A detailed history of Connective Capital Management, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Connective Capital Management, LLC holds 15,000 shares of FGEN stock, worth $138,750. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$138,750
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$0.25 - $6.65 $3,750 - $99,750
15,000 New
15,000 $79.5 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $867M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Connective Capital Management, LLC Portfolio

Follow Connective Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Capital Management, LLC with notifications on news.